Literature DB >> 27853923

The Cognitive and Behavioral Phenotypes of Individuals with CHRNA7 Duplications.

M A Gillentine1,2, L N Berry3,4, R P Goin-Kochel3,4, M A Ali1,2, J Ge1, D Guffey5, J A Rosenfeld1, V Hannig6, P Bader7, M Proud4,8, M Shinawi9, B H Graham1, A Lin10, S R Lalani1, J Reynolds11, M Chen12, T Grebe13, C G Minard5, P Stankiewicz1, A L Beaudet1, C P Schaaf14,15.   

Abstract

Chromosome 15q11q13 is among the least stable regions in the genome due to its highly complex genomic architecture. Low copy repeat elements at 15q13.3 facilitate recurrent copy number variants (CNVs), with deletions established as pathogenic and CHRNA7 implicated as a candidate gene. However, the pathogenicity of duplications of CHRNA7 is unclear, as they are found in affected probands as well as in reportedly healthy parents and unaffected control individuals. We evaluated 18 children with microduplications involving CHRNA7, identified by clinical chromosome microarray analysis (CMA). Comprehensive phenotyping revealed high prevalence of developmental delay/intellectual disability, autism spectrum disorder, and attention deficit/hyperactivity disorder. As CHRNA7 duplications are the most common CNVs identified by clinical CMA, this study provides anticipatory guidance for those involved with care of affected individuals.

Entities:  

Keywords:  15q13.3 microduplication; Autism spectrum disorder; Behavior; CHRNA7; Neurodevelopment

Mesh:

Substances:

Year:  2017        PMID: 27853923      PMCID: PMC5443344          DOI: 10.1007/s10803-016-2961-8

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  19 in total

1.  Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological?

Authors:  Przemyslaw Szafranski; Christian P Schaaf; Richard E Person; Ian B Gibson; Zhilian Xia; Sangeetha Mahadevan; Joanna Wiszniewska; Carlos A Bacino; Seema Lalani; Lorraine Potocki; Sung-Hae Kang; Ankita Patel; Sau Wai Cheung; Frank J Probst; Brett H Graham; Marwan Shinawi; Arthur L Beaudet; Pawel Stankiewicz
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

Review 2.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

Review 3.  The human clinical phenotypes of altered CHRNA7 copy number.

Authors:  Madelyn A Gillentine; Christian P Schaaf
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

Review 4.  Phenotypic variability and genetic susceptibility to genomic disorders.

Authors:  Santhosh Girirajan; Evan E Eichler
Journal:  Hum Mol Genet       Date:  2010-08-31       Impact factor: 6.150

5.  Phenotypic heterogeneity of genomic disorders and rare copy-number variants.

Authors:  Santhosh Girirajan; Jill A Rosenfeld; Bradley P Coe; Sumit Parikh; Neil Friedman; Amy Goldstein; Robyn A Filipink; Juliann S McConnell; Brad Angle; Wendy S Meschino; Marjan M Nezarati; Alexander Asamoah; Kelly E Jackson; Gordon C Gowans; Judith A Martin; Erin P Carmany; David W Stockton; Rhonda E Schnur; Lynette S Penney; Donna M Martin; Salmo Raskin; Kathleen Leppig; Heidi Thiese; Rosemarie Smith; Erika Aberg; Dmitriy M Niyazov; Luis F Escobar; Dima El-Khechen; Kisha D Johnson; Robert R Lebel; Kiana Siefkas; Susie Ball; Natasha Shur; Marianne McGuire; Campbell K Brasington; J Edward Spence; Laura S Martin; Carol Clericuzio; Blake C Ballif; Lisa G Shaffer; Evan E Eichler
Journal:  N Engl J Med       Date:  2012-09-12       Impact factor: 91.245

6.  The complex behavioral phenotype of 15q13.3 microdeletion syndrome.

Authors:  Mark N Ziats; Robin P Goin-Kochel; Leandra N Berry; May Ali; Jun Ge; Danielle Guffey; Jill A Rosenfeld; Patricia Bader; Michael J Gambello; Varina Wolf; Lynette S Penney; Ryan Miller; Robert Roger Lebel; Jeffrey Kane; Kristine Bachman; Robin Troxell; Gary Clark; Charles G Minard; Pawel Stankiewicz; Arthur Beaudet; Christian P Schaaf
Journal:  Genet Med       Date:  2016-03-10       Impact factor: 8.822

7.  Clinical phenotype of the recurrent 1q21.1 copy-number variant.

Authors:  Raphael Bernier; Kyle J Steinman; Beau Reilly; Arianne Stevens Wallace; Elliott H Sherr; Nicholas Pojman; Heather C Mefford; Jennifer Gerdts; Rachel Earl; Ellen Hanson; Robin P Goin-Kochel; Leandra Berry; Stephen Kanne; LeeAnne Green Snyder; Sarah Spence; Melissa B Ramocki; David W Evans; John E Spiro; Christa L Martin; David H Ledbetter; Wendy K Chung
Journal:  Genet Med       Date:  2015-06-11       Impact factor: 8.822

8.  Copy number variations and cognitive phenotypes in unselected populations.

Authors:  Katrin Männik; Reedik Mägi; Aurélien Macé; Ben Cole; Anna L Guyatt; Hashem A Shihab; Anne M Maillard; Helene Alavere; Anneli Kolk; Anu Reigo; Evelin Mihailov; Liis Leitsalu; Anne-Maud Ferreira; Margit Nõukas; Alexander Teumer; Erika Salvi; Daniele Cusi; Matt McGue; William G Iacono; Tom R Gaunt; Jacques S Beckmann; Sébastien Jacquemont; Zoltán Kutalik; Nathan Pankratz; Nicholas Timpson; Andres Metspalu; Alexandre Reymond
Journal:  JAMA       Date:  2015-05-26       Impact factor: 56.272

9.  Association study of CHRFAM7A copy number and 2 bp deletion polymorphisms with schizophrenia and bipolar affective disorder.

Authors:  Rachel H Flomen; David A Collier; Sarah Osborne; Janet Munro; Gerome Breen; David St Clair; Andrew J Makoff
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-09-05       Impact factor: 3.568

10.  Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3.

Authors:  Nigel M Williams; Barbara Franke; Eric Mick; Richard J L Anney; Christine M Freitag; Michael Gill; Anita Thapar; Michael C O'Donovan; Michael J Owen; Peter Holmans; Lindsey Kent; Frank Middleton; Yanli Zhang-James; Lu Liu; Jobst Meyer; Thuy Trang Nguyen; Jasmin Romanos; Marcel Romanos; Christiane Seitz; Tobias J Renner; Susanne Walitza; Andreas Warnke; Haukur Palmason; Jan Buitelaar; Nanda Rommelse; Alejandro Arias Vasquez; Ziarih Hawi; Kate Langley; Joseph Sergeant; Hans-Christoph Steinhausen; Herbert Roeyers; Joseph Biederman; Irina Zaharieva; Hakon Hakonarson; Josephine Elia; Anath C Lionel; Jennifer Crosbie; Christian R Marshall; Russell Schachar; Stephen W Scherer; Alexandre Todorov; Susan L Smalley; Sandra Loo; Stanley Nelson; Corina Shtir; Philip Asherson; Andreas Reif; Klaus-Peter Lesch; Stephen V Faraone
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

View more
  20 in total

1.  Systematic Review and Meta-Analysis of the Clinical Utility of the ADOS-2 and the ADI-R in Diagnosing Autism Spectrum Disorders in Children.

Authors:  Jenna B Lebersfeld; Marissa Swanson; Christian D Clesi; Sarah E O'Kelley
Journal:  J Autism Dev Disord       Date:  2021-01-21

2.  CHRNA7 copy number gains are enriched in adolescents with major depressive and anxiety disorders.

Authors:  Madelyn A Gillentine; Ricardo Lozoya; Jiani Yin; Christopher M Grochowski; Janson J White; Christian P Schaaf; Chadi A Calarge
Journal:  J Affect Disord       Date:  2018-07-11       Impact factor: 4.839

3.  Nicotinic acetylcholine receptor subunit α7-knockout mice exhibit degraded auditory temporal processing.

Authors:  Richard A Felix; Vicente A Chavez; Dyana M Novicio; Barbara J Morley; Christine V Portfors
Journal:  J Neurophysiol       Date:  2019-05-22       Impact factor: 2.714

4.  Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.

Authors:  Madelyn A Gillentine; Jiani Yin; Aleksandar Bajic; Ping Zhang; Steven Cummock; Jean J Kim; Christian P Schaaf
Journal:  Am J Hum Genet       Date:  2017-11-09       Impact factor: 11.025

Review 5.  Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy.

Authors:  Feng Wei; Li-Min Yan; Tao Su; Na He; Zhi-Jian Lin; Jie Wang; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao
Journal:  Neurosci Bull       Date:  2017-05-09       Impact factor: 5.203

6.  CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents.

Authors:  Madelyn A Gillentine; Janson J White; Christopher M Grochowski; James R Lupski; Christian P Schaaf; Chadi A Calarge
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-08-17       Impact factor: 2.576

7.  Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Ariany Oliveira-Santos; Marisela Dagda; Dean J Burkin
Journal:  Hum Mol Genet       Date:  2022-07-21       Impact factor: 5.121

8.  CoDE-seq, an augmented whole-exome sequencing, enables the accurate detection of CNVs and mutations in Mendelian obesity and intellectual disability.

Authors:  Louise Montagne; Mehdi Derhourhi; Amélie Piton; Bénédicte Toussaint; Emmanuelle Durand; Emmanuel Vaillant; Dorothée Thuillier; Stefan Gaget; Franck De Graeve; Iandry Rabearivelo; Amélie Lansiaux; Bruno Lenne; Sylvie Sukno; Rachel Desailloud; Miriam Cnop; Ramona Nicolescu; Lior Cohen; Jean-François Zagury; Mélanie Amouyal; Jacques Weill; Jean Muller; Olivier Sand; Bruno Delobel; Philippe Froguel; Amélie Bonnefond
Journal:  Mol Metab       Date:  2018-05-16       Impact factor: 7.422

Review 9.  KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism.

Authors:  Isaac James Muyinda; Jae-Gwang Park; Eun-Jung Jang; Byong-Chul Yoo
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

Review 10.  Clinical Applications of Molecular Biomarkers in Prostate Cancer.

Authors:  Felipe Couñago; Fernando López-Campos; Ana Aurora Díaz-Gavela; Elena Almagro; Esaú Fenández-Pascual; Iván Henríquez; Rebeca Lozano; Estefanía Linares Espinós; Alfonso Gómez-Iturriaga; Guillermo de Velasco; Luis Miguel Quintana Franco; Ignacio Rodríguez-Melcón; José López-Torrecilla; Daniel E Spratt; Luis Leonardo Guerrero; Juan Ignacio Martínez-Salamanca; Elia Del Cerro
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.